1. Mixed-effects models for slope-based endpoints in clinical trials of chronic kidney disease

   Vonesh, E., Tighiouart, H., Ying, J., Heerspink, H. L., Lewis, J., Staplin, N., Inker, L. & Greene, T., 30-Sep-2019, In : Statistics in Medicine. 38, 22, p. 4218-4239 22 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency

   Levey, A. S., Gansevoort, R. T., Coresh, J., Inker, L. A., Heerspink, H. L., Grams, M. E., Greene, T., Tighiouart, H., Matsushita, K., Ballew, S. H., Sang, Y., Vonesh, E., Ying, J., Manley, T., de Zeeuw, D., Eckardt, K-U., Levin, A., Perkovic, V., Zhang, L. & Willis, K., 23-Aug-2019, In : American Journal of Kidney Diseases.

   Research output: Contribution to journal › Article › Academic › peer-review

3. 18F-FDG UPTAKE IN VISCERAL ADIPOSE TISSUE IS INVERSELY ASSOCIATED TO INSULIN RESISTANCE AND ADIPONECTIN

   Reijrink, M., Spoor, D. S., Antunes, I. F., Greuter, M. J. W., Pol, R. A., Heerspink, H. J. L., Hillebrands, J. L., Slart, R. H. J. A. & Mulder, D. J., Aug-2019, In : ATHEROSCLEROSIS. 287, p. E130-E130 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

4. Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trial

   Koomen, J. V., Heerspink, H. J. L., Schrieks, I. C., Schwartz, G. G., Lincoff, A. M., Nicholls, S. J., Svensson, A., Wedel, H., Weichert, A., Grobbee, D. E. & Stevens, J., 29-Aug-2019, In : Diabetes obesity & metabolism.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Association between individual cholesterol and proteinuria response and exposure to atorvastatin or rosuvastatin

   Kroonen, M. Y. A. M., Stevens, J., de Zeeuw, D. & Heerspink, H. J. L., 15-Aug-2019, In : Diabetes obesity & metabolism.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (270) »

1. Basis principes in farmacokinetiek van geneesmiddelen en invloed van obesitas

   Jasper Stevens (Speaker), Hiddo Heerspink (Speaker)

   29-Jan-2019

   Activity: Talk or presentation › Professional

2. Challenges with Personalized Medicine

   Hiddo Lambers Heerspink (Speaker)

   Oct-2018

   Activity: Talk or presentation › Professional

3. Invited lecture Annual Society of Japanese Diabetes Association

   Hiddo Lambers Heerspink (Speaker)

   Oct-2018

   Activity: Talk or presentation › Professional

View all (13) »